Холандија -
Холандски -
CBG-MEB (College ter Beoordeling van Geneesmiddelen)
oxycodon hcl 5 mg teva, tabletten met verlengde afgifte
teva nederland b.v. - oxycodonhydrochloride samenstelling overeenkomend met ; oxycodon - tablet met verlengde afgifte - carmellose natrium (e 466) ; cellulose, microkristallijn (e 460) ; ethylcellulose (e 462) ; hyprolose (e 463) ; hypromellose (e 464) ; macrogol 3350 ; magnesiumstearaat (e 470b) ; maÏszetmeel ; polyvinylalcohol (e1203) ; propyleenglycol (e 1520) ; saccharose ; siliciumdioxide (e 551) ; sugar spheres ; talk (e 553 b) ; titaandioxide (e 171), - oxycodone
Холандија -
Холандски -
myHealthbox
actirob® b
bayer ag - emulgeerbaar concentraat - 842 g/l veresterde koolzaadolie
Европска Унија -
Холандски -
EMA (European Medicines Agency)
jcovden (previously covid-19 vaccine janssen)
janssen-cilag international nv - adenovirus type 26 encoding the sars-cov-2 spike glycoprotein (ad26.cov2-s) - covid-19 virus infection - vaccins - jcovden is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 18 years of age and older. het gebruik van dit vaccin moet gebeuren in overeenstemming met officiële aanbevelingen.
Холандија -
Холандски -
myHealthbox
roundup® ultimate
bayer ag - waterige oplossing - 480 g/l glyfosaat
Холандија -
Холандски -
Adama
phantom
adama - suspensie concentraat (sc) - folpet + tebuconazool - fungicide
Холандија -
Холандски -
Adama
solofol®
adama - waterdispergeerbaar granulaat (wg) - folpet - fungicide
Холандија -
Холандски -
Adama
spirit®
adama - suspensie concentraat (sc) - folpet + tebuconazool - fungicide
Европска Унија -
Холандски -
EMA (European Medicines Agency)
adcirca (previously tadalafil lilly)
eli lilly nederland b.v. - tadalafil - hypertensie, pulmonair - urologica - adultstreatment of pulmonary arterial hypertension (pah) classified as who functional class ii and iii, to improve exercise capacity (see section 5. de werkzaamheid is aangetoond bij idiopathisch pak (ipah) en bij pah gerelateerd aan collageenvasculaire ziekte. paediatric populationtreatment of paediatric patients aged 2 years and above with pulmonary arterial hypertension (pah) classified as who functional class ii and iii.